<DOC>
	<DOCNO>NCT00584766</DOCNO>
	<brief_summary>To determine therapeutic efficacy high-dose cyclophosphamide BCNU autologous bone marrow transplantation initial tumor cytoreduction patient receptor-negative metastatic breast carcinoma determine optimal time CyBCNU-ABMT initial development metastatic breast carcinoma</brief_summary>
	<brief_title>Intensive Combo Chemo With Autologous BM Rescue Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>breast carcinoma first clinical evidence metastatic disease must measurable disease physical exam , xray , scan Age &lt; equal 55 performance status 02 ca n't one prior chemotherapy regimen ca n't concurrent hormonal therapy brain metastasis previous pelvic radiation history another malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>